Indoco Remedies
Indoco Remedies Performance
Day Range
- Low
- High
52 Week Range
- Low
- High
- Open Price
- Previous Close
- Volume
Start SIP in Indoco Remedies
Start SIPIndoco Remedies Investment Rating
-
Master Rating:
-
Indoco Remedies has an operating revenue of Rs. 1,668.62 Cr. on a trailing 12-month basis. An annual revenue growth of 8% is good, Pre-tax margin of 12% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 15%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and around 5% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 27 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 427 | 399 | 405 | 395 | 400 |
| Operating Expenses Qtr Cr | 363 | 337 | 345 | 337 | 328 |
| Operating Profit Qtr Cr | 64 | 62 | 88 | 71 | 80 |
| Depreciation Qtr Cr | 18 | 17 | 16 | 20 | 18 |
| Interest Qtr Cr | 9 | 7 | 5 | 4 | 3 |
| Tax Qtr Cr | 13 | 10 | 18 | 10 | 19 |
| Net Profit Qtr Cr | 25 | 28 | 50 | 38 | 40 |
Indoco Remedies Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 1
- Bearish Moving Average
- ___
- 15
- 20 Day
- ₹340.61
- 50 Day
- ₹339.11
- 100 Day
- ₹344.84
- 200 Day
- ₹354.47
- 20 Day
- ₹343.98
- 50 Day
- ₹332.61
- 100 Day
- ₹345.96
- 200 Day
- ₹355.56
Indoco Remedies Resistance and Support
| Resistance | |
|---|---|
| First Resistance | ₹356.97 |
| Second Resistance | ₹361.79 |
| Third Resistance | ₹369.47 |
| RSI | 46.18 |
| MFI | 21.59 |
| MACD Single Line | 3.04 |
| MACD | 2.25 |
| Support | |
|---|---|
| First Resistance | ₹344.47 |
| Second Resistance | ₹336.79 |
| Third Resistance | ₹331.97 |
Indoco Remedies Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 448,587 | 17,566,667 | 39.16 |
| Week | 156,895 | 7,053,990 | 44.96 |
| 1 Month | 119,839 | 4,507,132 | 37.61 |
| 6 Month | 181,324 | 5,546,697 | 30.59 |
Indoco Remedies Result Highlights
Indoco Remedies Synopsis
NSE-Medical-Diversified
Indoco Remedies is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1666.69 Cr. and Equity Capital is Rs. 18.43 Cr. for the Year ended 31/03/2023. Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913.| Market Cap | 3,072 |
| Sales | 1,667 |
| Shares in Float | 3.78 |
| No of funds | 70 |
| Yield | 0.64 |
| Book Value | 3 |
| U/D Vol ratio | 0.8 |
| LTDebt / Equity | 15 |
| Alpha | -0.01 |
| Beta | 0.58 |
Indoco Remedies
| Owner Name | Mar-23 | Dec-22 | Sep-22 | Jun-22 |
|---|---|---|---|---|
| Promoters | 58.69% | 58.69% | 58.69% | 58.69% |
| Mutual Funds | 17.18% | 17.28% | 17.27% | 17.39% |
| Insurance Companies | 0.11% | 0.06% | 0.06% | 0.13% |
| Foreign Portfolio Investors | 1.55% | 1.23% | 1.19% | 1.17% |
| Individual Investors | 16.48% | 16.73% | 16.85% | 17.22% |
| Others | 5.99% | 6.01% | 5.94% | 5.4% |
Indoco Remedies Management
| Name | Designation |
|---|---|
| Mr. Suresh G Kare | Chairman |
| Ms. Aditi Panandikar | Managing Director |
| Mr. Sundeep V Bambolkar | Joint Managing Director |
| Dr. Anand Nadkarni | Non Executive Director |
| Mr. D M Gavaskar | Independent Director |
| Mr. Rajiv P Kakodkar | Independent Director |
| Dr.(Ms.) Vasudha V Kamat | Independent Director |
| Mr. Abhijit Y Gore | Independent Director |
Indoco Remedies Forecast
Price Estimates
Indoco Remedies Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-05-23 | Audited Results & Final Dividend | |
| 2023-01-24 | Quarterly Results | |
| 2022-11-10 | Quarterly Results | |
| 2022-08-09 | Quarterly Results | |
| 2022-05-17 | Audited Results & Final Dividend |
Indoco Remedies FAQs
What is Share Price of Indoco Remedies ?
Indoco Remedies share price is ₹333 As on 06 June, 2023 | 01:46
What is the Market Cap of Indoco Remedies ?
The Market Cap of Indoco Remedies is ₹3071.8 Cr As on 06 June, 2023 | 01:46
What is the P/E ratio of Indoco Remedies ?
The P/E ratio of Indoco Remedies is 21.6 As on 06 June, 2023 | 01:46
What is the PB ratio of Indoco Remedies ?
The PB ratio of Indoco Remedies is 3 As on 06 June, 2023 | 01:46